Merck & Co Inc: (NYSE: MRK)
$47.33
2.12 (4.69%)
Volume 46,907,653
May 21 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Financial Overview
P/E
| PE (forward) | 13.55 |
| Trailing 12 Months | 12.86 |
| PEG Ratio | 5.17 |
Price Ratios
| Price/Book | 2.57 |
| Price/Cash Flow | 7.69 |
| Price / Sales | 3.10 |
Current Ratio
| 03-31-13 | 1.87 |
| 12-31-12 | 1.90 |
| 09-30-12 | 2.32 |
Net Margin
| 03-31-13 | 14.10 |
| 12-31-12 | 14.09 |
| 09-30-12 | 14.16 |
Inventory Turnover
| 03-31-13 | 2.49 |
| 12-31-12 | 2.54 |
| 09-30-12 | 2.57 |
EPS Growth
| vs. Previous Year | -14.14 |
| vs. Previous Quarter | 2.41 |
ROE
| 03-31-13 | 19.88 |
| 12-31-12 | 20.53 |
| 09-30-12 | 21.17 |
Quick Ratio
| 03-31-13 | 1.51 |
| 12-31-12 | 1.54 |
| 09-30-12 | 1.89 |
Pre-Tax Margin
| 03-31-13 | 16.84 |
| 12-31-12 | 18.49 |
| 09-30-12 | 18.79 |
Debt-to-Equity
| 03-31-13 | 0.29 |
| 12-31-12 | 0.29 |
| 09-30-12 | 0.30 |
Sales Growth
| vs. Previous Year | -9.04 |
| vs. Previous Quarter | -9.09 |
ROA
| 03-31-13 | 10.64 |
| 12-31-12 | 11.09 |
| 09-30-12 | 11.53 |
Operating Margin
| 03-31-13 | 24.41 |
| 12-31-12 | 24.83 |
| 09-30-12 | 25.47 |
Book Value
| 03-31-13 | 18.40 |
| 12-31-12 | 18.24 |
| 09-30-12 | 19.11 |
Debt to Capital
| 03-31-13 | 22.44 |
| 12-31-12 | 22.66 |
| 09-30-12 | 23.19 |
